A detailed history of Voloridge Investment Management, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 380,641 shares of IONS stock, worth $13.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
380,641
Holding current value
$13.9 Million
% of portfolio
0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$40.06 - $51.86 $15.2 Million - $19.7 Million
380,641 New
380,641 $15.2 Million
Q1 2024

May 15, 2024

SELL
$42.03 - $53.55 $3.06 Million - $3.9 Million
-72,754 Reduced 27.55%
191,367 $8.3 Million
Q4 2023

Feb 14, 2024

BUY
$43.39 - $51.63 $11.5 Million - $13.6 Million
264,121 New
264,121 $13.4 Million
Q2 2023

Aug 14, 2023

BUY
$34.73 - $43.33 $185,736 - $231,728
5,348 New
5,348 $219,000
Q4 2022

Feb 14, 2023

BUY
$37.12 - $46.52 $1.14 Million - $1.43 Million
30,709 New
30,709 $1.16 Million
Q2 2022

Aug 15, 2022

SELL
$31.71 - $43.0 $6.01 Million - $8.15 Million
-189,556 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$29.88 - $37.04 $2.31 Million - $2.86 Million
-77,289 Reduced 28.96%
189,556 $7.02 Million
Q4 2021

Feb 14, 2022

BUY
$25.61 - $35.1 $6.83 Million - $9.37 Million
266,845 New
266,845 $8.12 Million
Q4 2020

Feb 16, 2021

SELL
$45.3 - $60.27 $4.3 Million - $5.72 Million
-94,905 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$47.45 - $62.95 $4.5 Million - $5.97 Million
94,905 New
94,905 $4.5 Million
Q3 2019

Nov 14, 2019

SELL
$59.06 - $72.15 $6.03 Million - $7.36 Million
-102,063 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$62.09 - $86.14 $5.95 Million - $8.26 Million
95,907 Added 1557.94%
102,063 $6.56 Million
Q1 2019

May 15, 2019

BUY
$52.92 - $81.17 $325,775 - $499,682
6,156 New
6,156 $500,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.19B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.